Swipe to learn more about Cy Huynh, Senior Director of Data Product. This AANHPI Heritage Month, we’re honored to spotlight members of our team and celebrate the stories, traditions, and experiences that shape who they are. From honoring family sacrifices and cultural resilience to celebrating food, language, and community, Cy’s reflections are a reminder that identity lives in both the everyday and the extraordinary. Thank you, Cy, for sharing your story and helping us celebrate the richness and diversity of the AANHPI diaspora this month and beyond. 🌏✨
GeneDx
Biotechnology Research
Stamford, CT 66,776 followers
Empowering everyone to live their healthiest life through genomics
About us
We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™, the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by expert geneticists and granted FDA Breakthrough Device Designation – enabling clinicians to deliver precise, fast, and actionable diagnoses. With over 25 years of innovation, more than 4,800 genetic diseases diagnosed, and over 1,000 scientific publications, we’re building the genomic intelligence network that’s shaping the future of precision medicine: for patients, providers, and partners alike.
- Website
-
https://www.genedx.com
External link for GeneDx
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Stamford, CT
- Type
- Public Company
- Specialties
- genetic testing, rare genetic disorders, molecular diagnostics, whole genome sequencing, next generation sequencing, neonatal screening, whole exome sequencing, genome, genetics, artificial intelligence, and exome
Locations
-
Primary
Get directions
333 Ludlow Street
8th Floor
Stamford, CT 06902, US
-
Get directions
207 Perry Pkwy
Gaithersburg, Maryland 20877, US
Employees at GeneDx
Updates
-
What becomes possible when you combine deep genomic data and phenotypic data with claims? GeneDx Infinity™ showcases how one of the world’s largest genomic datasets can help uncover new insights in cardiomyopathy, demonstrating the potential of integrated genomic and clinical data to accelerate discovery and expand understanding of inherited heart disease. Explore the latest data highlights from GeneDx → https://genedx.co/4db2AiI
-
-
What happens when clinical-grade genomic data meets real-world longitudinal insights? Biopharma teams gain a clearer understanding of patient populations, disease burden, healthcare utilization, and therapeutic opportunity: enabling smarter, faster drug development decisions. Join Lisa Gurry and Colton Frazer on Thursday, June 4 at 1 PM EDT | 10 AM PDT as they discuss how integrated genomic and claims data can support precision clinical trials, natural history modeling, biomarker discovery, and evidence generation at scale using GeneDx Infinity™, one of the world’s largest clinically derived genomic datasets. Register now → https://genedx.co/4di3Sbq
-
Same program you trust, now with a new name. The Epilepsy Partnership Program is now the Epilepsy Answers Partnership Program. While the name has changed, everything else stays the same: same eligibility, same ordering process, and same support. This program continues to help you move forward with guideline-recommended exome testing—even when coverage is denied or unavailable—so you can avoid delays and access more comprehensive answers for your patients. Getting to answers sooner matters. Need a refresher? Our team is here and happy to help → https://genedx.co/4eSn0hB
-
-
GeneDx reposted this
We’re excited to share that the sponsored genetic testing program developed in partnership with GeneDx, is officially live! NPC Detect expands access to exome sequencing for eligible individuals with suspected Niemann-Pick disease type C (NPC). The goal is to help clinicians reach answers faster, support earlier diagnosis, and improve clinical decision-making in this rare, progressive condition. We’re excited to share that the sponsored genetic testing program developed in partnership with GeneDx, is officially live! NPC Detect expands access to exome sequencing for eligible individuals with suspected Niemann-Pick disease type C (NPC). The goal is to help clinicians reach answers faster, support earlier diagnosis, and improve clinical decision-making in this rare, progressive condition.
-
-
At GeneDx, the #1 Mindset Awards recognize employees who exemplify the behaviors and values that help us achieve our goals together. These peer-nominated awards celebrate team members who lead by example, raise the bar, and embody what it means to “Set the Pace” through collaboration, innovation, accountability, and excellence. Please join us in celebrating our recent honorees: Luke Watson, Nicole Dais, MPH, PMP, CSPO, Rachel Roesch, Elizabeth Butler, and Raxit Patel. Thank you for the passion, energy, and impact you bring to GeneDx every day. Your contributions help strengthen our culture, support our teams, and ultimately make a meaningful difference for the patients and families we serve. 💙 Drop a comment below to help celebrate this incredible group! 👏
-
We are excited to be at #ISPOR2026! Stop by booth #837 to connect with our team and explore GeneDx Infinity™, one of the world’s largest genomic datasets powering insights across rare disease and precision medicine. We’re looking forward to meeting with attendees and discussing how genomic data can help advance research, diagnostics, and patient care.
-
-
Genetic testing in neurology is evolving beyond a one-time event. At #AAN2026, one message came through clearly: reanalysis and updated testing approaches are creating new opportunities to uncover answers that may have been missed previously. As knowledge advances, exome and genome sequencing are increasingly being discussed as first-tier testing approaches in neurologic care. The conversation is shifting from “Was testing done?” to: ✔️ When was it done? ✔️ What type of testing was used? ✔️ Should results be revisited over time? Our latest blog explores how neurologists are thinking differently about longitudinal genetic care, diagnostic clarity, patient management, and access to testing resources. Read more: https://genedx.co/3RJJh7y
-
GeneDx reposted this
👋👋👋 #ISPORAnnual! GeneDx is excited to be here. Come and see us at booth #837! We will show you GeneDx Infinity, one of the world’s largest genomic datasets. With Andrew Pollock, PhD, Sindhu Raghunandan, PhD, Colleen Caleshu MSc, LCGC, PhD Candidate, Jessica Merritt, Susan Williams, Amanda Ventrella, Bridget Boelter #ISPOR #ISPOR2026
-
-
We’re growing at GeneDx! If you’re passionate about shaping the future of genomics, healthcare, and patient impact, check out a few of our open roles below: • Director, Customer & Market Insights: https://genedx.co/4numJUe • Sales Trainer, Sales Enablement and Effectiveness: https://genedx.co/4uQWaef • Manager, Internal Audit: https://genedx.co/4uPwhf1 • Strategic Account Director - NICU (Mid South): https://genedx.co/49L5xEb • Strategic Account Director - NICU (West TX): https://genedx.co/4nxFfej Know someone who’d be a great fit? Tag them below or share with your network 💙